title: Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia.
authors.affiliation: Department of Dermatology, Referral Centre for Auto-immune and Toxic Bullous Diseases, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France.
authors.forename: Livia
authors.initials: L
authors.lastname: Delgado
authors.affiliation: Laboratory of Hematology, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France.
authors.forename: Stephane
authors.initials: S
authors.lastname: Giraudier
authors.affiliation: Department of Pathology, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Ortonne
authors.affiliation: Department of Dermatology, Referral Centre for Auto-immune and Toxic Bullous Diseases, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France.
authors.forename: Ouidad
authors.initials: O
authors.lastname: Zehou
authors.affiliation: Department of Hematology, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Cordonnier
authors.affiliation: Laboratory of Pharmacology, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Hulin
authors.affiliation: Department of Dermatology, Referral Centre for Auto-immune and Toxic Bullous Diseases, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France; INSERM, CIC 006, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Chosidow
authors.affiliation: Laboratory of Hematology, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France.
authors.forename: Michel
authors.initials: M
authors.lastname: Tulliez
authors.affiliation: Department of Dermatology, Referral Centre for Auto-immune and Toxic Bullous Diseases, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France; LIC EA4393, Henri-Mondor Hospital (Assistance Publique -Hôpitaux de Paris), UPEC, F-94010 Créteil, France. Electronic address: laurence.allanore@hmn.ap-hp.fr.
authors.forename: Laurence
authors.initials: L
authors.lastname: Valeyrie-Allanore
mesh_terms: D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy*; D011537:Pruritus / Q000139:chemically induced*